ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VCEL Vericel Corporation

44.19
-0.07 (-0.16%)
Mar 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 408,016
Bid Price 42.81
Ask Price 45.62
News -
Day High 44.63

Low
28.02

52 Week Range

High
50.09

Day Low 43.48
Company Name Stock Ticker Symbol Market Type
Vericel Corporation VCEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -0.16% 44.19 20:00:00
Open Price Low Price High Price Close Price Prev Close
44.20 43.48 44.63 44.19 44.26
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,871 408,016 $ 44.13 $ 18,006,341 - 28.02 - 50.09
Last Trade Time Type Quantity Stock Price Currency
17:39:18 average 54,383 $ 44.19 USD

Vericel Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.13B 48.29M - 197.52M -3.18M -0.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vericel News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VCEL Message Board. Create One! See More Posts on VCEL Message Board See More Message Board Posts

Historical VCEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week44.9045.6243.4844.36551,475-0.71-1.58%
1 Month48.8650.0943.4846.11489,853-4.67-9.56%
3 Months35.0050.0932.3141.24581,3829.1926.26%
6 Months34.2650.0930.1838.56445,9499.9328.98%
1 Year29.6450.0928.0236.53386,17914.5549.09%
3 Years52.0268.9417.3038.32458,420-7.83-15.05%
5 Years19.1968.946.7829.84507,72425.00130.28%

Vericel Description

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

Your Recent History

Delayed Upgrade Clock